Academic Rank:
Clinical Assistant Professor of Pathology, University of British Columbia (UBC)
Consultant Anatomic Pathologist, Royal Columbian Hospital (RCH)
Medical Lead, Pre & Post Analytic, Royal Columbian Hospital (RCH)
Medical Director, Laboratory Medicine, Chilliwack General Hospital (CGH)
Royal Columbian Hospital
Short Bio:

Dr. Alaghehbandan is a board-certified Anatomic Pathologist and a Clinical Epidemiologist, currently serving as a consultant Surgical Pathologist at the Royal Columbian Hospital in BC, Canada. He holds a faculty appointment at the University of British Columbia (UBC) and is the Medical Director for Laboratory Medicine Program at Chilliwack General Hospital as well as the Medical Lead for Pre & Post Analytic Division at the Royal Columbian Hospital in Fraser Health Authority.

Dr. Alaghehbandan received his medical degree in Tehran, Iran, followed by Master of Science in Clinical Epidemiology at Memorial University in Newfoundland, Canada. Upon completing his residency training in Canada, he served as a clinical fellow in Surgical (Selective) Pathology at Washington University School of Medicine, Barnes Jewish Hospital in St. Louis, MO, USA, where he trained in oncopathology. He is board-certified in Anatomic Pathology in Canada, the USA and Europe. He is also a Fellow of the Royal College of Physicians of Canada (FRCPC), the College of American Pathologists (FCAP), and the New York Academy of Medicine (FNYAM).

Dr. Alaghehbandan’s area of practice includes oncologic surgical pathology with special interest in urologic, breast and gynecologic pathology as well as non-GYN and FNA cytopathology practice. His primary research interest is focused on urologic surgical pathology including unusual variants of renal cell carcinomas, their biologic behaviors, molecular characteristics and potential targeted therapies (i.e., immunotherapies). He is also involved in assessing the effectiveness of novel biomarkers in GYN cytopathology (i.e. cervical lesions) as well as the development of external quality assurance and proficiency testing in various cancers. Being a minority Kurd from Iran, his other longstanding research interests include injury (i.e., burns and suicide) and chronic disease epidemiology as well as health issues related to vulnerable populations such as women/children and Indigenous peoples from human rights and social justice perspectives. Dr. Alaghehbandan also has extensive experience in developing and utilizing administrative health databases for conducting population health research and surveillance.

As a former senior public servant, he mentored junior epidemiologists and enhanced research capacity building in government and community settings in Canada. Considering other aspect of his expertise in supporting policy-decision making, he provided briefings and advice to government executives and decision makers on a variety of topics such as adverse health events and chronic diseases (i.e., Commission of Inquiry on Hormone Receptor Testing in Newfoundland).

Dr. Alaghehbandan has great interest and passion in global health and is a strong believer and advocate in building capacity and highlighting the improvements pathologists can make for populations challenged with cancers in resource-poor settings. He has been privileged to be involved in teaching, promoting and practicing surgical pathology in sub-Saharan Africa, a region with high prevalence of AIDS and pertinent malignancies.

He is a frequent contributor to national and international conferences and has authored and/or co-authored numerous articles in both pathology and epidemiology fields, with an h-index of 18 demonstrating a tenured record in academia and research. He has served as an editorial board member and ad hoc reviewer on a number of peer-reviewed journals. He also serves as an active member on national and international committees. Further, he had the privilege to serve as a long-term member of the Board of Directors of a Human Rights organization in Canada.

Academic background

  • Fellow, College of American Pathologists (FCAP). 2014
  • Board-certified, Anatomic Pathology, European Board of Pathology (EBP). 2013
  • Board-certified, Anatomic Pathology, Diplomate of the American Board of Pathology (ABP). 2013
  • Fellow, Royal College of Physicians of Canada (FRCPC), Anatomic Pathology. 2013
  • Fellowship, Surgical (Selective) Pathology, Washington University School of Medicine, Barnes Jewish Hospital, USA. 2013-2014
  • Residency, Anatomic Pathology, Memorial University and UBC. 2009-2013
  • Fellow, New York Academy of Medicine (NYAM). 2012
  • Memorial University, MSc (Clinical Epidemiology).  2010
  • Iran University of Medical Sciences, MD. 1998


Reza Alaghehbandan PUBMED

Primary Research Area
Secondary Research Area
Molecular Pathology & Cell Biology

Research Interest

  • Urologic, Breast and Gynecologic Surgical Pathology
  • Oncopathology and Epidemiology
  • Secondary use of administrative health databases

Teaching Interest

Residency training and medical student teaching.